Skip to main content
. Author manuscript; available in PMC: 2020 Mar 15.
Published in final edited form as: Clin Cancer Res. 2018 Nov 29;25(6):1913–1922. doi: 10.1158/1078-0432.CCR-18-1176

Figure 3: PD-1+ T cells have decreased TCR diversity compared to PD-1 cells.

Figure 3:

A) The number of estimated unique TCR sequences in PD-1 and PD-1+ populations in healthy donor PBMC, glioma patient PBMC, and glioma patient TILs. Each point represents a single patient. Circle points represent healthy donor PBMCs. Square points represent glioma patient PBMCs. Triangle points represent glioma patient TILs. (**P≤0.005).

B) The frequency of a specific TCR rearrangement in the populations. The populations shown are the CD3+ PD-1 or CD3+ PD-1+ populations from healthy donor PBMCs (dotted bar), glioma patient PBMCs (the checkerboard bar), and glioma patient TILs (slanted stripes bar)

HHS Vulnerability Disclosure